Casos de bronquiolite em beb�s caem ap�s chegada de vacina para gestantes no SUS

A recent decline in severe respiratory cases among infants under six months old has been observed since Brazil's public health system, the SUS, started offering a vaccine against the respiratory syncytial virus (RSV) to pregnant women. RSV is the leading cause of bronchiolitis and respiratory disease hospitalizations in infants. This strategic move has not only reduced infant morbidity but also offers a significant public health benefit, demonstrating the effectiveness of maternal vaccination in preventing serious respiratory conditions in newborns.